PF614
PF614-201
Phase 2 small_molecule completed
Quick answer
PF614 for Acute Pain is a Phase 2 program (small_molecule) at Ensysce Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ensysce Biosciences
- Indication
- Acute Pain
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed